(Q37723938)

22 August 2017

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series (English)

1 reference

22 August 2017

0 references

1 reference

12

Marcella Mottolese

0 references

Valerie Speirs

21

Valerie Speirs

0 references

Andrew M. Hanby

19

Andrew M Hanby

1 reference

22 August 2017

Matthew P Humphries

1

0 references

Maria Litwiniuk

Maria Litwiniuk

10

0 references

Ian Ellis

Ian O Ellis

17

0 references

Abeer M. Shaaban

Abeer M Shaaban

20

0 references

author name string

Sreekumar Sundara Rajan

2

1 reference

22 August 2017

Hedieh Honarpisheh

3

1 reference

22 August 2017

Gabor Cserni

4

1 reference

22 August 2017

Jo Dent

5

1 reference

22 August 2017

Laura Fulford

6

1 reference

22 August 2017

Lee B Jordan

7

1 reference

22 August 2017

J Louise Jones

8

1 reference

22 August 2017

Rani Kanthan

9

1 reference

22 August 2017

Anna Di Benedetto

11

1 reference

22 August 2017

Marcella Mottolese

12

1 reference

22 August 2017

Elena Provenzano

13

1 reference

22 August 2017

Sami Shousha

14

1 reference

22 August 2017

Mark Stephens

15

1 reference

22 August 2017

Janina Kulka

16

1 reference

22 August 2017

Akinwale N Titloye

18

1 reference

22 August 2017

language of work or name

English

0 references

publication date

28 March 2017

1 reference

full work available at URL

22 August 2017

http://eprints.whiterose.ac.uk/113765/

content deliverer

White Rose Research Online

0 references

published in

Scientific Reports

1 reference

22 August 2017

7

1 reference

22 August 2017

45293

1 reference

Creative Commons Attribution 4.0 International

22 August 2017

start time

28 March 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/srep45293

0 references

cites work

Clinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Obesity and male breast cancer: provocative parallels?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Age at diagnosis in relation to survival following breast cancer: a cohort study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast carcinoma: a clinicopathological and immunohistochemical characterization study.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Pioneer transcription factors: establishing competence for gene expression

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast carcinoma: increased awareness needed

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

FOXA1 is a key determinant of estrogen receptor function and endocrine response

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Multidisciplinary meeting on male breast cancer: summary and research recommendations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

REporting recommendations for tumour MARKer prognostic studies (REMARK)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Breast carcinoma in men: a population-based study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Prognostic variables in male breast cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Androgen receptor expression in male breast carcinoma: lack of clinicopathological association

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast cancer: Looking for better prognostic subgroups.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

A role for the androgen receptor in the treatment of male breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Androgen receptor and antiandrogen therapy in male breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Survivin and COX-2 expression in male breast carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Immunohistochemical investigation of CD34 antigen in male breast carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Her-2/neu gene amplification and protein expression in primary male breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Prognostic factors in male breast cancer: a population-based study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Molecular markers in male breast carcinoma.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Gender-associated expression of tumor markers and a small gene set in breast carcinoma.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Immunophenotyping of male breast cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Positive progesterone receptors and cell proliferation index: an independent association with breast cancer in males

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Prolactin receptor expression in gynaecomastia and male breast carcinoma

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5368596

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSREP45293

Key signalling nodes in mammary gland development and cancer: Myc.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSREP45293

Decline in breast cancer incidence in the United States: what about male breast cancer?

21 January 2018

1 reference

12 December 2020

Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome

1 reference

12 December 2020

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

1 reference

12 December 2020

FOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and Survival

1 reference

12 December 2020

Male breast cancer: pathological and immunohistochemical features

1 reference

12 December 2020

Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast

1 reference

12 December 2020

Immunohistochemical study of p53 and Ki67 in a group of patients with mammary carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/SREP45293

1 reference

Dimensions Publication ID

22 August 2017

0 references

0 references

1084133129

0 references

Microsoft Academic ID

0 references

1 reference

22 August 2017

1 reference